Australia markets closed

IGM Biosciences, Inc. (IGMS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.70+0.95 (+14.07%)
At close: 04:00PM EDT
8.24 +0.54 (+7.01%)
Pre-market: 06:21AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
2,130
2,130
1,069
0
0
Operating expenses
Research development
215,519
215,519
179,289
127,026
65,030
Selling general and administrative
50,072
50,072
49,736
38,297
18,250
Total operating expenses
265,591
265,591
229,025
165,323
83,280
Operating income or loss
-263,461
-263,461
-227,956
-165,323
-83,280
Total other income/expenses net
-20
-20
-181
159
1,925
Income before tax
-245,738
-245,738
-221,102
-165,164
-81,355
Income tax expense
678
678
0
0
-
Income from continuing operations
-246,416
-246,416
-221,102
-165,164
-81,355
Net income
-246,416
-246,416
-221,102
-165,164
-81,355
Net income available to common shareholders
-246,416
-246,416
-221,102
-165,164
-81,355
Basic EPS
-4.90
-
-5.32
-4.93
-2.65
Diluted EPS
-4.90
-
-5.32
-4.93
-2.65
Basic average shares
48,402
-
41,544
33,480
30,748
Diluted average shares
48,402
-
41,544
33,480
30,748